Our vision is to improve the treatment of severe diseases. Working with the medicines of the future we focus on oncology.
Human Health
Our main goal is to develop new pharmaceuticals with high versatility were there are wide-spread medical needs.Further reading »
Animal Health
Animal Health develops and improves existing medical treatments focusing on oncology. Further reading »
The Share
Latest News
FDA grants Paccal® Vet Minor Use designation for mammary tumors
January 16 2012Oasmia Pharmaceutical, Uppsala, Sweden, has received Minor Use designation (MUMS) for Paccal® Vet on the indication nonresectable stage III, IV or V mammary carcinoma. MUMS allows for a seven year market exclusivity when registered and eligibility for conditional approval.
Further reading »
Interim report May 1 - October 31 2011
December 8 2011Further reading »
Publication of change in the total number of shares and votes in Oasmia
October 31 2011Further reading »
